首页> 美国卫生研究院文献>Cells >Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer
【2h】

Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer

机译:具有干细胞性能的无凝胶3D肿瘤肿瘤将耐药性与转移结直肠癌中的顺铂和伊马替尼进行建模

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Researchers have developed several three-dimensional (3D) culture systems, including spheroids, organoids, and tumoroids with increased properties of cancer stem cells (CSCs), also called cancer-initiating cells (CICs). Drug resistance is a crucial issue involving recurrence in cancer patients. Many studies on anti-cancer drugs have been reported using 2D culture systems, whereas 3D cultured tumoroids have many advantages for assessing drug sensitivity and resistance. Here, we aimed to investigate whether Cisplatin (a DNA crosslinker), Imatinib (a multiple tyrosine kinase inhibitor), and 5-Fluorouracil (5-FU: an antimetabolite) alter the tumoroid growth of metastatic colorectal cancer (mCRC). Gene expression signatures of highly metastatic aggregative CRC (LuM1 cells) vs. low-metastatic, non-aggregative CRC (Colon26 and NM11 cells) were analyzed using microarray. To establish a 3D culture-based multiplexing reporter assay system, LuM1 was stably transfected with the Mmp9 promoter-driven ZsGreen fluorescence reporter gene, which was designated as LuM1/m9 cells and cultured in NanoCulture Plate®, a gel-free 3D culture device. LuM1 cells highly expressed mRNA encoding ABCG2 (a drug resistance pump, i.e., CSC/CIC marker), other CSC/CIC markers (DLL1, EpCAM, podoplanin, STAT3/5), pluripotent stem cell markers (Sox4/7, N-myc, GATA3, Nanog), and metastatic markers (MMPs, Integrins, EGFR), compared to the other two cell types. Hoechst efflux stem cell-like side population was increased in LuM1 (7.8%) compared with Colon26 (2.9%), both of which were markedly reduced by verapamil treatment, an ABCG2 inhibitor. Smaller cell aggregates of LuM1 were more sensitive to Cisplatin (at 10 μM), whereas larger tumoroids with increased ABCG2 expression were insensitive. Notably, Cisplatin (2 μM) and Imatinib (10 μM) at low concentrations significantly promoted tumoroid formation (cell aggregation) and increased Mmp9 promoter activity in mCRC LuM1/m9, while not cytotoxic to them. On the other hand, 5-FU significantly inhibited tumoroid growth, although not completely. Thus, drug resistance in cancer with increased stem cell properties was modeled using the gel-free 3D cultured tumoroid system. The tumoroid culture is useful and easily accessible for the assessment of drug sensitivity and resistance.
机译:研究人员开发了几种三维(3D)培养系统,包括癌症干细胞(CSCs)的性能增加的球状体,有机体,和肿瘤曲线,也称为癌症引发细胞(CICS)。耐药性是涉及癌症患者复发的重要问题。使用2D培养系统报告了许多关于抗癌药物的研究,而3D培养的肿瘤瘤具有评估药物敏感性和抗性的许多优点。在这里,我们旨在研究顺铂(DNA交联剂),伊马替尼(多酪氨酸激酶抑制剂)和5-氟尿嘧啶(5-FU:抗体粘土)改变转移性结直肠癌(MCRC)的肿瘤生长。使用微阵列分析了高转移性聚集CRC(LUM1细胞)与低转移,非聚合CRC(Colon26和NM11细胞)的基因表达签名。为了建立基于3D培养的复用报告结果测定系统,用MMP9启动子驱动的ZSGreen荧光报告基因稳定地转染,将其指定为LUM1 / M9细胞并以纳米培养板,无凝胶3D培养装置培养。 LUM1细胞高表达mRNA编码ABCG2(药物抵抗泵,即CSC / CIC标记),其他CSC / CIC标志物(DLL1,EPCAM,Podoplanin,DIS3 / 5),多能干细胞标记物(SOX4 / 7,N-MYC与其他两种细胞类型相比,GATA3,NANOG)和转移标记物(MMP,整合,EGFR)。 Hoechst Efflux干细胞状侧群在LUM1(7.8%)中增加(7.8%),与结肠26(2.9%)相比,通过维拉帕米治疗,ABCG2抑制剂都显着降低。 Lum1的较小细胞聚集体对顺铂(10μm)更敏感,而具有增加的ABCG2表达的肿瘤肿瘤也不敏感。值得注意的是,低浓度下的顺铂(2μm)和伊马替尼(10μm)显着促进了MCRC Lum1 / M9中的MMP9启动子活性,而不是细胞毒性。另一方面,5-FU显着抑制肿瘤生长,虽然没有完全。因此,使用无凝胶的3D培养的肿瘤系统模拟具有增加的干细胞性能增加的癌症的耐药性。肿瘤培养物可用,可容易地访问药物敏感性和抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号